Continued goals for this ongoing Outstanding Investigator Grant (OIG) are to develop and use biostatistical, biomathematical and epidemiologic methods aimed at reducing cancer occurrence. The research objectives are twofold: first, to develop new methods for the conduct of epidemiologic studies of cancer etiology in relation to modifiable personal characteristics, and second, to use these methods to collect and analyze data relating such characteristics to site- specific cancer occurrence. Both the statistical and epidemiologic work during the past four years has focussed on cancers of the colorectum, ovary, breast and prostate. The most important research accomplishments have been a study of colorectal cancer in Chinese in the US, Canada and China in relation to diet, physical activity and body size, a collaborative analysis of raw data from 12 US case- control studies of ovarian cancer, and three studies of prostate cancer. This work has been featured in editorials in several scientific journals. Future plans are to address statistical problems and epidemiologic issues that have emerged in the study of cancers of the prostate and ovary. Both the methodological and the epidemiologic effort will focus on improved understanding of the combined effects of hereditary predisposition and modifiable lifestyle characteristics in the etiologies of these cancers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
5R35CA047448-13
Application #
6150082
Study Section
Special Emphasis Panel (SRC (90))
Program Officer
Patel, Appasaheb1 R
Project Start
1989-04-01
Project End
2002-01-31
Budget Start
2000-02-01
Budget End
2002-01-31
Support Year
13
Fiscal Year
2000
Total Cost
$584,042
Indirect Cost
Name
Stanford University
Department
Miscellaneous
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Oakley-Girvan, Ingrid; Feldman, David; Eccleshall, T Ross et al. (2004) Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiol Biomarkers Prev 13:1325-30
Whittemore, A S; Balise, R R; Pharoah, P D P et al. (2004) Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. Br J Cancer 91:1911-5
Andrulis, Irene L; Anton-Culver, Hoda; Beck, Jeanne et al. (2002) Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat 20:65-73
Shih, Mei-Chiung; Whittemore, Alice S (2002) Tests for genetic association using family data. Genet Epidemiol 22:128-45
Gong, Gail; Oakley-Girvan, Ingrid; Wu, Anna H et al. (2002) Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 13:471-82
Whittemore, A S; Halpern, J (2001) Problems in the definition, interpretation, and evaluation of genetic heterogeneity. Am J Hum Genet 68:457-65
Shih, M C; Whittemore, A S (2001) Allele-sharing among affected relatives: non-parametric methods for identifying genes. Stat Methods Med Res 10:27-55
Hsieh, C L; Oakley-Girvan, I; Balise, R R et al. (2001) A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet 69:148-58
Whittemore, A S; Tu, I P (2000) Detection of disease genes by use of family data. I. Likelihood-based theory. Am J Hum Genet 66:1328-40
Gnagy, S; Ming, E E; Devesa, S S et al. (2000) Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use. Epidemiology 11:102-5

Showing the most recent 10 out of 42 publications